Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Degenerative Disc Disease
Interventions
DEVICE

NuBac

NuBac device implanted at the L4/5 level.

DEVICE

Prodisc-L

Prodisc-L implanted at the L4/5 level.

Trial Locations (17)

13790

Southern New York NeuroSurgical Group, Johnson City

14224

Buffalo Neurosurgery, Buffalo

28204

Carolina Neurosurgery and Spine Associates, Charlotte

33637

Florida Orthopaedic Institute, Tampa

37620

Neurospine Solutions, PC, Bristol

49855

Orthopaedic Surgical Associates, Marquette

53211

Milwaukee Spinal Specialists, Milwaukee

60453

Bone & Joint Physicians, Oak Lawn

63017

The Orthopedic Center of St. Louis, St Louis

66204

Heartland Hand & Spine Orthopedic Center, Merriam

80045

University of Colorado, Anschutz Outpatient Pavilion, Aurora

80538

The Spine Institute, Loveland

90211

Spine Group Beverly Hills, Beverly Hills

Tower Orthopedics & Sports Medicine, Beverly Hills

92324

Bergey Spine Institute, Colton

92354

Loma Linda University - Faculty Physicians, Loma Linda

97401

NeuroSpine Institute, Eugene

All Listed Sponsors
lead

Pioneer Surgical Technology, Inc.

INDUSTRY

NCT00931515 - Trial Evaluating the Safety and Effectiveness of NUBAC™ Disc Arthroplasty | Biotech Hunter | Biotech Hunter